Patient Engagement

How Oncologists are Coping with COVID-19

July 09, 2020

Report highlights how oncology practices are becoming more virtual-oriented in light of the global pandemic.

COVID & Chronic Disease: Meeting the Needs of Vulnerable Patients

June 01, 2020

Pharma companies are in a unique position to support and educate at-risk populations through patient services hubs.

Surfing the Wave: The Patient-Data Puzzle

October 08, 2019

While commercial websites can employ analytics to gain better snapshots of their visitors, pharma faces far greater challenges in using technology as a way to track and understand its consumers.

Innovation + Human Engagement = Optimal Patient Support

August 21, 2019

Patient support program providers should incorporate new technologies for more effective processes, but this should be matched with empathy, human connectivity and personalized clinical interventions, writes Tommy Bramley.

Pharma Medical Affairs: A Blueprint for Future

June 24, 2019

Changing customer preferences and a growing need for specialized knowledge are challenging the traditional scope of the medical affairs function. Learn about six ways pharma MA departments can drive more collaborative relationships with caregivers.

Patient Advocacy: The Corporate Mandate

March 21, 2019

Perspectives from big pharma and the rare disease space on how patient advocacy is evolving as a corporate function.

Patient Support Programs: Cost, Benefit, and Resourcing

March 18, 2019

Working group explores the challenges of patient support programs (PSPs) and market research programs (MRPs) for pharmacovigilance (PV) professionals-and solutions currently being put into practice.

Patients is a Virtue

March 14, 2019

Providers of patient service solutions for pharma companies share insights on the nuances of the "consumer' connection and the shifts taking place in making patient-centric programs and tools more alive for patients.

What Does Patient Centricity Look Like?

March 14, 2019

That often-muddled picture is becoming increasingly clearer in the patient and business context as different ways in which patients, patient communities, advocacy, and pharma engage each other converge.

John Crowley: Living the Mission

March 14, 2019

Amicus Therapeutics CEO John Crowley, whose biotech journey and quest to cure two of his kids of a rare genetic disease is well chronicled, discusses the growing role of the patient-centered view in company culture-not just in adding “deeper meaning” to drug development, but in building patient advocacy into everyday business practice and strategy.